Joseph Jimenez  had previously worked in consumer goods. 

He discusses how he’s attempting to change the company in a Q&A with the Wall Street Journal. Some of it’s your standard material about writing fewer power points and spending more time with customers, but he also gives an interesting example of how the industry can and must change in an age of budget crises: 

I also started to shift our business away from a transactional model that was focused on physically selling the drugs to delivering an outcome-based approach to add value beyond just the pill. I really believe that in the future, companies like Novartis are going to be paid on patient outcomes as opposed to selling the pill.

See on www.businessinsider.com